Neurochemical and genetic factors in panic disorder: a systematic review
Open Access
- 18 July 2024
- journal article
- review article
- Published by Springer Nature in Translational Psychiatry
- Vol. 14 (1) , 1-11
Abstract
This systematic review addresses the complex nature of Panic Disorder (PD), characterized by recurrent episodes of acute fear, with a focus on updating and consolidating knowledge regarding neurochemical, genetic, and epigenetic factors associated with PD. Utilizing the PRISMA methodology, 33 original peer-reviewed studies were identified, comprising 6 studies related to human neurochemicals, 10 related to human genetic or epigenetic alterations, and 17 animal studies. The review reveals patterns of altered expression in various biological systems, including neurotransmission, the Hypothalamic-Pituitary-Adrenal (HPA) axis, neuroplasticity, and genetic and epigenetic factors leading to neuroanatomical modifications. Noteworthy findings include lower receptor binding of GABAA and serotonin neurotransmitters in the amygdala. The involvement of orexin (ORX) neurons in the dorsomedial/perifornical region in triggering panic reactions is highlighted, with systemic ORX-1 receptor antagonists blocking panic responses. Elevated Interleukin 6 and leptin levels in PD patients suggest potential connections between stress-induced inflammatory changes and PD. Brain-derived neurotrophic factor (BDNF) and tyrosine receptor kinase B (TrkB) signaling are implicated in panic-like responses, particularly in the dorsal periaqueductal gray (dPAG), where BDNF’s panicolytic-like effects operate through GABAA-dependent mechanisms. GABAergic neurons’ inhibitory influence on dorsomedial and posterior hypothalamus nuclei is identified, potentially reducing the excitability of neurons involved in panic-like responses. The dorsomedial hypothalamus (DMH) is highlighted as a specific hypothalamic nucleus relevant to the genesis and maintenance of panic disorder. Altered brain lactate and glutamate concentrations, along with identified genetic polymorphisms linked to PD, further contribute to the intricate neurochemical landscape associated with the disorder. The review underscores the potential impact of neurochemical, genetic, and epigenetic factors on the development and expression of PD. The comprehensive insights provided by this systematic review contribute to advancing our understanding of the multifaceted nature of Panic Disorder and pave the way for targeted therapeutic strategies.Keywords
This publication has 59 references indexed in Scilit:
- The Hippocampus and Panic Disorder: Evidence from Animal and Human Studies2016
- Meta‐analysis argues for a female‐specific role ofMAOA‐uVNTR in panic disorder in four European populationsAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2012
- The norepinephrine transporter gene is a candidate gene for panic disorderJournal of Neural Transmission, 2011
- Differential familial liability of panic disorder and agoraphobiaDepression and Anxiety, 2007
- Panic Attacks in an Individual With Bilateral Selective Lesions of the AmygdalaArchives of Neurology, 2006
- The role of substance P in stress and anxiety responsesAmino Acids, 2006
- The Epidemiology of Panic Attacks, Panic Disorder, and Agoraphobia in the National Comorbidity Survey ReplicationArchives of General Psychiatry, 2006
- A controlled family study in panic disorderJournal of Psychiatric Research, 1993
- Substance K and substance P as possible endogenous substrates of angiotensin converting enzyme in the brainBiochemical and Biophysical Research Communications, 1985
- A Family Study of Panic DisorderArchives of General Psychiatry, 1983